| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.35 | 1e-15 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.23 | 4e-12 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-07 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-06 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-06 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-05 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-05 |